----

----

----

| ☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---------|------------------------------------------------------------------------------------------------|
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM                      TO                     |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

| Cayman Islands                                                 |   | 98-1581263                           |
|----------------------------------------------------------------|--------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization) |   | (I.R.S. Employer Identification No.) |
| 100 First Stamford Place, Suite 330Stamford, CT |   | 06902      |
|-------------------------------------------------|--------|------------|
| (Address of principal executive offices)        |   | (Zip Code) |
| Title of each class                                                                                               | Trading Symbol(s) | Name of each exchange on which registered |
|-------------------------------------------------------------------------------------------------------------------|-------------------|-------------------------------------------|
| Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant                       | HCMAU             | The Nasdaq Stock Market LLC               |
| Class A Ordinary Shares, par value $0.0001 per share                                                              | HCMA              | The Nasdaq Stock Market LLC               |
| Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at a price of $11.50 per share | HCMAW             | The Nasdaq Stock Market LLC               |

----

| Large accelerated filer | ☐ | Accelerated filer              | ☐ |
|-----------------------------------|---------|-------------------------------------|---------|
| Non-accelerated filer             | ☒ | Smaller reporting company | ☒ |
| Emerging growth company           | ☒ |                                     |         |

----

----

|     | Page     |
|----------|----------|
| PART I   |     | 1 |
|     | Item 1.  | Business | 1 |
|     | Item 1A. | Risk Factors | 22 |
|     | Item 1B. | Unresolved Staff Comments. | 58 |
|     | Item 2.  | Properties. | 58 |
|     | Item 3.  | Legal Proceedings. | 58 |
|     | Item 4.  | Mine Safety Disclosures. | 58 |
| PART II  |          | 59 |
|     | Item 5.  | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. | 59 |
|     | Item 6.  | [Reserved] | 60 |
|     | Item 7.  | Management’s Discussion and Analysis of Financial Condition and Results of Operations. | 60 |
|     | Item 7A. | Quantitative and Qualitative Disclosures about Market Risk | 63 |
|     | Item 8.  | Financial Statements and Supplementary Data. | 64 |
|     | Item 9.  | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure | 81 |
|     | Item 9A. | Controls and Procedures. | 81 |
|     | Item 9B. | Other Information. | 81 |
|     | Item 9C. | Disclosures Regarding Foreign Jurisdictions that Prevent Inspections. | 81 |
| PART III |          | 82 |
|     | Item 10. | Directors, Executive Officers and Corporate Governance. | 82 |
|     | Item 11. | Executive Compensation. | 89 |
|     | Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. | 90 |
|     | Item 13. | Certain Relationships and Related Transactions, and Director Independence. | 91 |
|     | Item 14. | Principal Accounting Fees and Services. | 93 |
| PART IV  |          | 94 |
|     | Item 15. | Exhibits, Financial Statement Schedules | 94 |

----

Table of Contents

----

Table of Contents

| Item1. | Business |
|--------|----------|

----

Table of Contents

|  | • | FinTech |
|--|---------|---------|
|  | • | Retail banking and payment transfer |
|--|---------|-------------------------------------|
|  | • | Payments processing |
|--|---------|---------------------|
|  | • | Insurance |
|--|---------|-----------|
|  | • | Asset and wealth management |
|--|---------|-----------------------------|
|  | • | Real estate |
|--|---------|-------------|
|  | • | Lending and leasing |
|--|---------|---------------------|
|  | • | Specialty Finance |
|--|---------|-------------------|
|  | • | Cybersecurity |
|--|---------|---------------|
|  | • | Data providers, cloud computing, security, etc. |
|--|---------|-------------------------------------------------|
|  | • | Digital assets and blockchain technology |
|--|---------|------------------------------------------|

|  | • | Established Businesses. We will seek to acquire established businesses that we believe are fundamentally sound, but in need of our assistance to                  maximize their potential value. This assistance could be financial, operational, strategic, or managerial; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|  | • | Early Stage Companies. We may target earlier stage companies which are at the forefront of shifts in the industry, have the potential to change                  the industry, and have the ability to significantly scale with our input of capital and management expertise; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Strong Management Teams. We have a preference for strong and experienced management teams that are looking for a partner in their growth; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Regular and Significant Cashflow. We look for companies with a history of regular and significant cashflow, as well as current and/or identified                  future profitability; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Scale. A target company should benefit from being a public company, with its access to capital markets to support its growth; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------|
|  | • | Cooperative Enhancement. We will look to identify companies that we believe will be enhanced by the experience of our management team that may be overlooked or unrecognized by                  less experienced operators; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Segment Leading Companies. Companies should exhibit segment leading characteristics and innovations to capture or create new or additional market share; and |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Growth. Targets should be on a path for considerable growth either organically or through further acquisitions. |
|--|---------|-----------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|   | • | subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after                our Business Combination; and |
|--------|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | • | cause us to depend on the marketing and sale of a single product or limited number of products or services. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------|
|   |  • | we issue ordinary shares that will be equal to or in excess of 20% of the number of our ordinary shares then-outstanding (other than in a public offering); |
|--------|---------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |  • | any of our directors, officers or substantial security holders (as defined by Nasdaq rules) has a 5% or greater interest, directly or indirectly, in the target business or assets to be                acquired or otherwise and the present or potential issuance of ordinary shares could result in an increase in issued and outstanding ordinary shares or voting power of 1% or more (or 5% or more if the related party involved is classified as                such solely because such person is a substantial security holder); or |
|--------|---------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | the issuance or potential issuance of ordinary shares will result in our undergoing a change of control. |
|--------|---------|----------------------------------------------------------------------------------------------------------|

|   | • | the timing of the transaction, including in the event we determine shareholder approval would require additional time and there is either not enough time to seek shareholder approval or                  doing so would place the company at a disadvantage in the transaction or result in other additional burdens on the company; |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|   | • | the expected cost of holding a shareholder vote; |
|--------|---------|--------------------------------------------------|

|   | • | the risk that the shareholders would fail to approve the proposed business combination; |
|--------|---------|-----------------------------------------------------------------------------------------|

|   | • | other time and budget constraints of the company; and |
|--------|---------|-------------------------------------------------------|

|   | • | additional legal complexities of a proposed business combination that would be time-consuming and burdensome to present to shareholders. |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

|   | • | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the                    tender offer rules; and |
|--------|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | file proxy materials with the SEC. |
|--------|---------|------------------------------------|

|   |  • | conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and |
|--------|---------------|-------------------------------------------------------------------------------------------------------------------------------------------|
|   |  • | file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial                business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. |
|--------|---------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|   | • | If we have not consummated an initial business combination within 15 months from the closing of the Public Offering, we will (i) cease all operations except for the purpose of winding up; (ii) as promptly                    as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the                    funds held in the trust account and not previously released to us to pay our taxes that were paid by us or are payable by us, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the                    then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably                    possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of                    creditors and the requirements of other applicable law; |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | Prior to or in connection with our initial business combination, we may not issue additional securities that would entitle the holders thereof to (i) receive funds from the trust account or (ii) vote as a                    class with our public shares (a) on our initial business combination or on any other proposal presented to shareholders prior to or in connection with the completion of an initial business combination or (b) to approve an amendment to                    our amended and restated memorandum and articles of association to (x) extend the time we have to consummate a business combination beyond 15 months from the closing of the Public Offering or (y) amend the foregoing provisions; |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | Although we do not intend to enter into a business combination with a target business that is affiliated with our sponsor, our directors or our officers, we are not prohibited from doing so. In the event                    we enter into such a transaction, we, or a committee of independent directors, will obtain an opinion from independent investment banking firm or another independent entity that commonly renders valuation opinions that such a business                    combination is fair to our company from a financial point of view; |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | If a shareholder vote on our initial business combination is not required by applicable law or stock exchange listing requirements and we do not decide to hold a shareholder vote for business or other                    reasons, we will offer to redeem our public shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, and will file tender offer documents with the SEC prior to completing our initial business combination which contain                    substantially the same financial and other information about our initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act; |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | So long as our securities are then listed on Nasdaq, our initial business combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the                    assets held in the trust account (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the trust account) at the time of the agreement to enter into the initial business                    combination; |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|   | • | If our shareholders approve an amendment to our amended and restated memorandum and articles of association (A) that would modify the substance or timing of our obligation to provide holders of our                      Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 15 months from                      the closing of the Public Offering or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares, we will provide our public shareholders with the opportunity to redeem all or a portion of                      their ordinary shares upon such approval at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously                      released to us to pay our taxes, if any, divided by the number of the then-outstanding public shares, subject to the limitations described herein; and |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | We will not effectuate our initial business combination solely with another blank check company or a similar company with nominal operations. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole; |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------|

|   | • | duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose; |
|--------|---------|------------------------------------------------------------------------------------------------------------------|

|   | • | directors should not improperly fetter the exercise of future discretion; |
|--------|---------|---------------------------------------------------------------------------|

----

Table of Contents

|   | • | duty to exercise powers fairly as between different sections of shareholders; |
|--------|---------|-------------------------------------------------------------------------------|

|   | • | duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | duty to exercise independent judgment. |
|--------|---------|----------------------------------------|

----

Table of Contents

|   | • | Our executive officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations                    and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our executive officers is engaged in several                    other business endeavors for which he may be entitled to substantial compensation, and our executive officers are not obligated to contribute any specific number of hours per week to our affairs. |
|--------|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | Our sponsor and each member of our management team have entered into an agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and public                    shares held by them in connection with (i) our initial business combination, and (ii) a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association (A) that would modify the substance or                    timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our                    initial business combination within 15 months from the closing of the Public Offering or during any Extension Period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares.                    Additionally, our sponsor, Cantor Fitzgerald and each member of our management team have agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares if we fail to complete our                    initial business combination within the prescribed time frame. If we do not complete our initial business combination within the prescribed time frame, the private placement warrants will expire worthless. Except as described herein,                    our initial shareholders have agreed not to transfer, assign or sell any of their founder shares until the earlier of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business                    combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days                    within any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our                    public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Except as described herein, the private placement warrants will not be transferable until 30 days following the completion of                    our initial business combination. Because our directors will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business                    with which to effectuate our initial business combination. |
|--------|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors is included by a                    target business as a condition to any agreement with respect to our initial business combination. In addition, our sponsor, officers and directors may sponsor, form or participate in blank check companies similar to ours during the                    period in which we are seeking an initial business combination. Any such companies may present additional conflicts of interest in pursuing an acquisition target, particularly in the event there is overlap among investment mandates. |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

| Item1A. | Risk Factors |
|---------|--------------|

|  | • | being a newly incorporated company with no operating history and no revenues; |
|--|---------|-------------------------------------------------------------------------------|
|  | • | our ability to complete our initial business combination, including risks arising from the uncertainty resulting from the COVID-19 pandemic; |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|  | • | our public shareholders’ ability to exercise redemption rights; |
|--|---------|-----------------------------------------------------------------------|
|  | • | the requirement that we complete our initial business combination within the prescribed time frame; |
|--|---------|-----------------------------------------------------------------------------------------------------|
|  | • | the possibility that Nasdaq may delist our securities from trading on its exchange; |
|--|---------|-------------------------------------------------------------------------------------|
|  | • | being declared an investment company under the Investment Company Act; |
|--|---------|------------------------------------------------------------------------|
|  | • | complying with changing laws and regulations; |
|--|---------|-----------------------------------------------|
|  | • | our ability to select an appropriate target business or businesses; |
|--|---------|---------------------------------------------------------------------|
|  | • | the performance of the prospective target business or businesses; |
|--|---------|-------------------------------------------------------------------|
|  | • | the pool of prospective target businesses available to us and the ability of our officers and directors to generate a number of potential business combination opportunities; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | the issuance of additional Class A ordinary shares in connection with a business combination that may dilute the interest of our shareholders; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | the incentives to our sponsor, officers and directors to complete a business combination to avoid losing their entire investment in us if our initial business combination is not completed; |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | HCM Investor Holdings, LLC and its affiliates manage a number of funds, separate accounts and other investment vehicles that may compete with us for business combination opportunities; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | our success in retaining or recruiting, or making changes required in, our officers, key employees or directors following our initial business combination; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | our ability to obtain additional financing to complete our initial business combination; |
|--|---------|------------------------------------------------------------------------------------------|
|  | • | our ability to amend the terms of warrants in a manner that may be adverse to the holders of public warrants; |
|--|---------|---------------------------------------------------------------------------------------------------------------|
|  | • | our ability to redeem your unexpired warrants prior to their exercise; |
|--|---------|------------------------------------------------------------------------|
|  | • | our public securities’ potential liquidity and trading; and |
|--|---------|-------------------------------------------------------------------|
|  | • | provisions in our amended and restated memorandum and articles of association and Cayman Islands law. |
|--|---------|-------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|  | • | restrictions on the nature of our investments; and |
|--|---------|----------------------------------------------------|
|  | • | restrictions on the issuance of securities, |
|--|---------|---------------------------------------------|
|  | • | registration as an investment company with the SEC; |
|--|---------|-----------------------------------------------------|
|  | • | adoption of a specific form of corporate structure; and |
|--|---------|---------------------------------------------------------|
|  | • | reporting, record keeping, voting, proxy and disclosure requirements and compliance with other rules and regulations that we are currently not subject to. |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

|  | • | may significantly dilute the equity interest of investors in the Public Offering, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of                Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | could cause a change in control if a substantial number of Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could                result in the resignation or removal of our present officers and directors; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants; and |
|--|---------|----------------------------------------------------------------------------------------------------------------|
|  | • | may not result in adjustment to the exercise price of our warrants. |
|--|---------|---------------------------------------------------------------------|

----

Table of Contents

|  | • | solely dependent upon the performance of a single business, property or asset; or |
|--|---------|-----------------------------------------------------------------------------------|
|  | • | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
|--|---------|-----------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|  | • | a limited availability of market quotations for our securities; |
|--|---------|-----------------------------------------------------------------|
|  | • | reduced liquidity for our securities; |
|--|---------|---------------------------------------|
|  | • | a determination that our Class A ordinary shares are a “penny stock” which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level                of trading activity in the secondary trading market for our securities; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | a limited amount of news and analyst coverage; and |
|--|---------|----------------------------------------------------|
|  | • | a decreased ability to issue additional securities or obtain additional financing in the future. |
|--|---------|--------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

|  | • | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios                or reserves without a waiver or renegotiation of that covenant; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
|--|---------|--------------------------------------------------------------------------------------------------------|
|  | • | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | our inability to pay dividends on our Class A ordinary shares; |
|--|---------|---------------------------------------------------------------------|
|  | • | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital                expenditures, acquisitions and other general corporate purposes; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------|
|  | • | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages                compared to our competitors who have less debt. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|  | • | costs and difficulties inherent in managing cross-border business operations; |
|--|---------|-------------------------------------------------------------------------------|
|  | • | rules and regulations regarding currency redemption; |
|--|---------|------------------------------------------------------|
|  | • | complex corporate withholding taxes on individuals; |
|--|---------|-----------------------------------------------------|
|  | • | laws governing the manner in which future business combinations may be effected; |
|--|---------|----------------------------------------------------------------------------------|
|  | • | exchange listing and/or delisting requirements; |
|--|---------|-------------------------------------------------|
|  | • | tariffs and trade barriers; |
|--|---------|-----------------------------|
|  | • | regulations related to customs and import/export matters; |
|--|---------|-----------------------------------------------------------|
|  | • | local or regional economic policies and market conditions; |
|--|---------|------------------------------------------------------------|
|  | • | unexpected changes in regulatory requirements; |
|--|---------|------------------------------------------------|
|  | • | longer payment cycles; |
|--|---------|------------------------|
|  | • | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
|--|---------|--------------------------------------------------------------------------------------------------|
|  | • | currency fluctuations and exchange controls; |
|--|---------|----------------------------------------------|
|  | • | rates of inflation; |
|--|---------|---------------------|
|  | • | challenges in collecting accounts receivable; |
|--|---------|-----------------------------------------------|
|  | • | cultural and language differences; |
|--|---------|------------------------------------|
|  | • | employment regulations; |
|--|---------|-------------------------|
|  | • | underdeveloped or unpredictable legal or regulatory systems; |
|--|---------|--------------------------------------------------------------|
|  | • | corruption; |
|--|---------|-------------|
|  | • | protection of intellectual property; |
|--|---------|--------------------------------------|
|  | • | social unrest, crime, strikes, riots and civil disturbances; |
|--|---------|--------------------------------------------------------------|
|  | • | regime changes and political upheaval; |
|--|---------|----------------------------------------|
|  | • | terrorist attacks, natural disasters and wars; and |
|--|---------|----------------------------------------------------|
|  | • | deterioration of political relations with the United States. |
|--|---------|--------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|   | • | we have a board that includes a majority of “independent directors,” as defined under the rules of Nasdaq; |
|--------|---------|------------------------------------------------------------------------------------------------------------------------|
|  | • | we have a compensation committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | we have a nominating and corporate governance committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and                responsibilities. |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| Item 1B. | Unresolved Staff Comments. |
|----------|----------------------------|
| Item 2. | Properties. |
|---------|-------------|
| Item 3. | Legal Proceedings. |
|---------|--------------------|
| Item 4. | Mine Safety Disclosures. |
|---------|--------------------------|

----

Table of Contents

| Item 5. | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. |
|---------|---------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| Item 6. | [Reserved] |
|---------|------------|
| Item 7. | Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
|---------|----------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

| Item 7A. | Quantitative and Qualitative Disclosures about Market Risk |
|----------|------------------------------------------------------------|

----

Table of Contents

| Item8. |  Financial Statements and Supplementary Data. |
|--------|----------------------------------------------------|

| Report of Independent Registered Public Accounting Firm (PCAOB ID# 688)                                                       | 65       |
|-------------------------------------------------------------------------------------------------------------------------------|----------|
| Financial Statements:                                                                                                         |          |
| Balance Sheet as of December 31, 2021                                                                                         | 66       |
| Statement of Operations for the period from February 5, 2021 (inception) through December 31, 2021                            | 67       |
| Statement of Changes in Shareholders’ Equity for the period from February 5, 2021 (inception) through December 31, 2021 | 68       |
| Statement of Cash Flows for the period from February 5, 2021 (inception) through December 31, 2021                            | 69       |
| Notes to Financial Statements                                                                                                 | 70 to 80 |

----

Table of Contents

----

Table of Contents

| ASSETS                                                                                                                 |   |   |    |
|------------------------------------------------------------------------------------------------------------------------|--------|--------|---------|
| Current asset – cash                                                                                             |   | $      | 158     |   |
| Deferred offering costs                                                                                                |   |   | 341,864 |   |
| TOTAL ASSETS                                                                                                           |   | $      | 342,022 |   |
|                                                                                                                        |   |   |    |   |
| LIABILITIES AND SHAREHOLDERS’ EQUITY                                                                             |   |   |    |   |
| Current liabilities                                                                                                    |   |   |    |   |
| Accrued offering costs                                                                                                 |   |   | 124,308 |   |
| Promissory note — related party                                                                                  |   |   | 208,500 |   |
| Total Liabilities                                                                                                      |   |   | 332,808 |   |
|                                                                                                                        |   |   |    |   |
| Commitments and Contingencies                                                                                          |   |   |    |   |
|                                                                                                                        |   |   |    |   |
| Shareholders’ Equity                                                                                             |   |   |    |   |
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding                    |   |   |    |   |
| Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; no shares issued and outstanding            |   |   |    |   |
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 10,062,500 shares issued and outstanding (1) |   |   | 1,006   |   |
| Additional paid-in capital                                                                                             |   |   | 23,994  |   |
| Accumulated deficit                                                                                                    |   |   | (15,786 | ) |
| Total Shareholders’ Equity                                                                                       |   |   | 9,214   |   |
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY                                                                       |   | $      | 342,022 |   |
| (1) | Included an aggregate of up to 1,312,500 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option was exercised (see Note 5). On January                5, 2022, the Company effected a share capitalization in which the Sponsor was issued an additional 2,875,000 ordinary shares so that the Sponsor owns an aggregate of 10,062,500 Founder Shares. All share and per share amounts have been                retroactively restated for the share capitalization. All share and per-share amounts have been retroactively restated to reflect the reverse share split on Founder Shares (see Note 5). |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| Formation and operating costs                              |   | $      | 15,786    |   |
|------------------------------------------------------------|--------|--------|-----------|--------|
| Net Loss                                                   |   | $      | (15,786   | )      |
|                                                            |   |   |      |   |
| Weighted average shares outstanding, basic and diluted (1) |   | $      | 8,590,090 |   |
|                                                            |   |   |      |   |
| Basic and diluted net loss per ordinary shares             |   | $      | (0.00     | )      |
| (1) | Excluded an aggregate of up to 1,312,500 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option was exercised (see Note 5). On January                5, 2022, the Company effected a share capitalization in which the Sponsor was issued an additional 2,875,000 ordinary shares so that the Sponsor owns an aggregate of 10,062,500 Founder Shares. All share and per share amounts have been                retroactively restated for the share capitalization. All share and per-share amounts have been retroactively restated to reflect the reverse share split on Founder Shares (see Note 5). |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|                                              |   | Class BOrdinary Shares |    |    | Additional Paid-inCapital |    |    | AccumulatedDeficit |    |    | Total Shareholders’Equity |    |
|---------------------------------------------------|--------|------------------------|--------------|--------------|---------------------------|--------------|--------------|--------------------|--------------|--------------|---------------------------------|--------------|
|                                                   |   | Shares                 |         |         | Amount                    |
| Balance — February 5, 2021 (inception)      |   |                   | —      |         |                      | $            | —      |               |         | $            | —                         |         |   | $ | — |   |   | $ | — |   |
|                                                   |   |                   |         |         |                      |         |         |               |         |         |                            |         |   |   |   |   |   |   |   |   |
| Issuance of Class B ordinary shares to Sponsor(1) |   |                   | 10,062,500   |         |                      |         | 1,006        |               |         |         | 23,994                          |         |   |   | — |   |   |   | 25,000 |   |
|                                                   |   |                   |         |         |                      |         |         |               |         |         |                            |         |   |   |   |   |   |   |   |   |
| Net loss                                          |   |                   | —      |         |                      |         | —      |               |         |         | —                         |         |   |   | (15,786 | ) |   |   | (15,786 | ) |
|                                                   |   |                   |         |         |                      |         |         |               |         |         |                            |         |   |   |   |   |   |   |   |   |
| Balance — December 31, 2021                 |   |                   | 10,062,500   |         |                      | $            | 1,006        |               |         | $            | 23,994                          |         |   | $ | (15,786 | ) |   | $ | 9,214 |   |
| (1) | Included an aggregate of up to 1,312,500 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option was exercised (see Note 5). On January                5, 2022, the Company effected a share capitalization in which the Sponsor was issued an additional 2,875,000 ordinary shares so that the Sponsor owns an aggregate of 10,062,500 Founder Shares. All share and per share amounts have been                retroactively restated for the share capitalization. All share and per-share amounts have been retroactively restated to reflect the reverse share split on Founder Shares (see Note 5). |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| Cash Flows from Operating Activities:                                                           |   |        |     |
|-------------------------------------------------------------------------------------------------|--------|--------|----------|
| Net loss                                                                                        |   | $      | (15,786  | ) |
| Adjustments to reconcile net loss to net cash used in operating activities:                     |   |   |     |   |
| Payment of formation costs through issuance of Class B ordinary shares                          |   |   | 5,000    |   |
| Net cash used in operating activities                                                           |   |   | (10,786  | ) |
|                                                                                                 |   |   |     |   |
| Cash Flows from Financing Activities:                                                           |   |   |     |   |
| Proceeds from promissory note — related party                                             |   |   | 208,500  |   |
| Payment of offering costs                                                                       |   |   | (197,556 | ) |
| Net cash provided by financing activities                                                       |   |   | 10,944   |   |
|                                                                                            |   |   |     |   |
| Net Change in Cash                                                                              |   |   | 158      |   |
| Cash – Beginning                                                                          |   |   | —  |   |
| Cash – Ending                                                                             |   | $      | 158      |   |
|                                                                                                 |   |   |     |   |
| Non-cash investing and financing activities:                                                    |   |   |     |   |
| Deferred offering costs included in accrued offering costs                                      |   | $      | 124,308  |   |
| Deferred offering costs paid by Sponsor in exchange for the issuance of Class B ordinary shares |   | $      | 20,000   |   |

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|   | ● | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------|
|   | ● | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for                identical or similar instruments in markets that are not active; and |
|--------|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | ● | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which                one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the                fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

|   | ● | in whole and not in part; |
|--------|---------|---------------------------|
|   | ● | at a price of $0.01 per Public Warrant; |
|--------|---------|-----------------------------------------|
|   | ● | upon not less than 30 days’ prior written notice of redemption to each warrant holder; and |
|--------|---------|-------------------------------------------------------------------------------------------------------|
|   | ● | if, and only if, the last reported sale price of the Class A Ordinary Shares has been at least $18.00 per share (subject to adjustment in compliance with the public warrant agreement) for any ten trading days                within the 20-trading-day period ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of the Public Warrants. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

| Item 9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure |
|---------|--------------------------------------------------------------------------------------|
| Item 9A. | Controls and Procedures. |
|----------|--------------------------|
| Item 9B. | Other Information. |
|----------|--------------------|

| Item9C. | Disclosures Regarding Foreign Jurisdictions that Prevent Inspections. |
|---------|-----------------------------------------------------------------------|

----

Table of Contents

| Item 10. | Directors, Executive Officers and Corporate Governance. |
|----------|---------------------------------------------------------|
| Name            |  | Age |  | Title                                           |
|-----------------|--|-----|--|-------------------------------------------------|
| Shawn Matthews  |  | 55  |  | Chairman and Chief Executive Officer            |
| James Bond      |  | 51  |  | President, Chief Financial Officer and Director |
| Jacob Loveless  |  | 41  |  | Director                                        |
| Steven Bischoff |  | 64  |  | Director                                        |
| David Goldfarb  |  | 64  |  | Director                                        |

----

Table of Contents

----

Table of Contents

|  | • | meeting with our independent registered public accounting firm regarding, among other issues, audits, and adequacy of our accounting and control systems; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | monitoring the independence of the independent registered public accounting firm; |
|--|---------|-----------------------------------------------------------------------------------|
|  | • | verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law; |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | inquiring and discussing with management our compliance with applicable laws and regulations; |
|--|---------|-----------------------------------------------------------------------------------------------|
|  | • | pre-approving all audit services and permitted non-audit services to be performed by our independent registered public accounting firm, including the fees and terms of the services to be performed; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | appointing or replacing the independent registered public accounting firm; |
|--|---------|----------------------------------------------------------------------------|
|  | • | determining the compensation and oversight of the work of the independent registered public accounting firm (including resolution of disagreements between management and the independent auditor regarding                financial reporting) for the purpose of preparing or issuing an audit report or related work; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial                statements or accounting policies; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | monitoring compliance on a quarterly basis with the terms of this offering and, if any noncompliance is identified, immediately taking all action necessary to rectify such noncompliance or otherwise causing                compliance with the terms of this offering; and |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | reviewing and approving all payments made to our existing shareholders, executive officers or directors and their respective affiliates. Any payments made to members of our audit committee will be reviewed                and approved by our board of directors, with the interested director or directors abstaining from such review and approval. |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|  | • | should have demonstrated notable or significant achievements in business, education or public service; |
|--|---------|--------------------------------------------------------------------------------------------------------|
|  | • | should possess the requisite intelligence, education and experience to make a significant contribution to the board of directors and bring a range of skills, diverse perspectives and backgrounds to its                deliberations; and |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | should have the highest ethical standards, a strong sense of professionalism and intense dedication to serving the interests of the shareholders. |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such                goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | reviewing and approving the compensation of all of our other Section 16 executive officers; |
|--|---------|---------------------------------------------------------------------------------------------|
|  | • | reviewing our executive compensation policies and plans; |
|--|---------|----------------------------------------------------------|

----

Table of Contents

|  | • | implementing and administering our incentive compensation equity-based remuneration plans; |
|--|---------|--------------------------------------------------------------------------------------------|

|  | • | assisting management in complying with our proxy statement and annual report disclosure requirements; |
|--|---------|-------------------------------------------------------------------------------------------------------|

|  | • | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | producing a report on executive compensation to be included in our annual proxy statement; and |
|--|---------|------------------------------------------------------------------------------------------------|

|  | • | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
|--|---------|----------------------------------------------------------------------------------------------------|

|  | • | duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole; |
|--|---------|---------------------------------------------------------------------------------------------------------------------------|
|  | • | duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose; |
|--|---------|------------------------------------------------------------------------------------------------------------------|
|  | • | directors should not improperly fetter the exercise of future discretion; |
|--|---------|---------------------------------------------------------------------------|
|  | • | duty to exercise powers fairly as between different sections of shareholders; |
|--|---------|-------------------------------------------------------------------------------|
|  | • | duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | duty to exercise independent judgment. |
|--|---------|----------------------------------------|

----

Table of Contents

| Individual      |   | Entity                         |   | Entity’s Business       |   | Affiliation              |
|-----------------|--------|--------------------------------|--------|-------------------------------|--------|--------------------------|
| Shawn Matthews  |   | Hondius Capital Management, LP |   | Investment Management         |   | Chief Investment Officer |
|            |   |                           |   |                          |   |                     |
| James Bond      |   | Hondius Capital Management, LP |   | Investment Management         |   | Chief Operating Officer  |
|            |   |                           |   |                          |   |                     |
| Jacob Loveless  |   | Edgemesh Corporation           |   | Technology and Infrastructure |   | Chief Executive Officer  |
|            |   |                           |   |                          |   |                     |
| Steven Bischoff |   | Atlantic Home Loans            |   | Investment Management         |   | Executive Vice President |
|            |   |                           |   |                          |   |                     |
| David Goldfarb  |   | Chauncey Advisors LLC          |   | Investment Management         |   | Chief Executive Officer  |

----

Table of Contents

|  | • | Our executive officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between                our operations and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our executive officers is engaged in                several other business endeavors for which he may be entitled to substantial compensation, and our executive officers are not obligated to contribute any specific number of hours per week to our affairs. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Our initial shareholders subscribed for founder shares prior to the date of this prospectus and will purchase private placement warrants in a transaction that will close simultaneously                with the closing of this offering. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Our sponsor and each member of our management team have entered into an agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder                shares and public shares held by them in connection with (i) our initial business combination, and (ii) a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association (A) that would modify the                substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete                our initial business combination within 15 months from the closing of this offering or during any Extension Period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares. Additionally,                our sponsor, Cantor Fitzgerald and each member of our management team have agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares if we fail to complete our initial business                combination within the prescribed time frame. If we do not complete our initial business combination within the prescribed time frame, the private placement warrants will expire worthless. Except as described herein, our initial                shareholders have agreed not to transfer, assign or sell any of their founder shares until the earlier of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if                the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading                day period commencing at least 150 days after our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having                the right to exchange their ordinary shares for cash, securities or other property. Except as described herein, the private placement warrants will not be transferable until 30 days following the completion of our initial business                combination. Because our directors will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our                initial business combination. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors                is included by a target business as a condition to any agreement with respect to our initial business combination. In addition, our sponsor, officers and directors may sponsor, form or participate in blank check companies similar to ours                during the period in which we are seeking an initial business combination. Any such companies may present additional conflicts of interest in pursuing an acquisition target, particularly in the event there is overlap among investment                mandates. |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| Item 11. | Executive Compensation. |
|----------|-------------------------|

----

Table of Contents

| Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. |
|----------|-------------------------------------------------------------------------------------------------|
|   | • | each person known by us to be the beneficial owner of more than 5% of our outstanding ordinary shares; |
|--------|---------|--------------------------------------------------------------------------------------------------------|
|   | • | each of our executive officers and directors that beneficially own ordinary shares; and |
|--------|---------|-----------------------------------------------------------------------------------------|
|   | • | all our executive officers and directors as a group. |
|--------|---------|------------------------------------------------------|
|                                                                        | Current Ownership                      |
|-----------------------------------------------------------------------------|----------------------------------------|
| Name and Address of Beneficial Owner(1)                                     | Number of Shares Beneficially Owned(2) |   | Approximate Percentage ofOutstanding OrdinaryShares |
| HCM Investor Holdings, LLC                                                  | 9,987,500(3)                           |   |   | 25.7% |
| Shawn Matthews                                                              | 9,987,500(3)                           |   |   | 25.7% |
| James Bond                                                                  | —                                |   |   | — |
| Jacob Loveless(4)                                                           | 25,000                                 |   |   | * |
| Steven Bischoff(4)                                                          | 25,000                                 |   |   | * |
| David Goldfarb(4)                                                           | 25,000                                 |   |   | * |
| All executive officers and directors as a group   (5 individuals) |   10,062,500                      |   |   | 25.9% |

----

| * | Less than one percent. |
|---|------------------------|
|   | (1) | Unless otherwise noted, the business address of each of our shareholders is 100 First Stamford Place, Suite 330, Stamford, Connecticut 06902. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------|
|   | (2) | Interests shown consist solely of founder shares, classified as Class B ordinary shares. Such shares will automatically convert into Class A ordinary shares at the time of our initial                business combination. |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | (3) | Our sponsor is the record holder of such shares. Mr. Matthews, our Chairman and Chief Executive Officer, is the managing member of our sponsor. As such, each of the sponsor and Mr.                Matthews may be deemed to share beneficial ownership of the ordinary shares held directly by our sponsor. Mr. Matthews disclaims any beneficial ownership of the ordinary shares held directly by our sponsor, and disclaims any beneficial                ownership of such shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | (4) | Our sponsor transferred 25,000 founder shares to each of our independent directors at the closing of the Public Offering. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| Item 13. | Certain Relationships and Related Transactions, and Director Independence. |
|----------|----------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

| Item 14. | Principal Accounting Fees and Services. |
|----------|-----------------------------------------|

----

Table of Contents

| Item15. |  Exhibits, Financial Statement Schedules |
|---------|-----------------------------------------------|

|   | (a) | The following documents are filed as part of this Form 10-K: |
|--------|-----|--------------------------------------------------------------|

|   | (1) | Financial Statements: See “Index to Financial Statements” at Item 8. Financial Statements and Supplementary Data” herein. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | Exhibits: The exhibits listed in the accompanying index to exhibits are filed or incorporated by reference as part of this Annual Report on Form 10-K. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------|

| No.     |        | Description of Exhibit                                                                                                                                                                                    |
|---------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.1     |        | Amended and Restated Memorandum and Articles of Association.(1)                                                                                                                                           |
| 4.1     |   | Specimen Unit Certificate.(2)                                                                                                                                                                             |
| 4.2     |   | Specimen Class A Ordinary Share Certificate.(2)                                                                                                                                                           |
| 4.3     |   | Specimen Warrant Certificate.(2)                                                                                                                                                                          |
| 4.4     |        | Warrant Agreement, dated January 20, 2022, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent.(1)                                                            |
| 10.1    |        | Investment Management Trust Agreement, dated January 20, 2022, by and between the Company and Continental Stock Transfer & Trust Company, as trustee.(1)                                              |
| 10.2    |        | Registration Rights Agreement, dated January 20, 2022, by and among the Company, the Sponsor and the Underwriter.(1)                                                                                      |
| 10.3(a) |        | Private Placement Warrants Purchase Agreement, dated January 20, 2022, by and between the Company and the Sponsor.(1)                                                                                     |
| 10.3(b) |        | Private Placement Warrants Purchase Agreement, dated January 20, 2022, by and between the Company and the Underwriter.(1)                                                                                 |
| 10.4    |   | Form of Indemnity Agreement.(2)                                                                                                                                                                           |
| 10.5    |   | Amended and Restated Promissory Note, dated December 30, 2021, issued by the Registrant to the Sponsor.(2)                                                                                                |
| 10.6    |   | Securities Subscription Agreement, dated as of February 10, 2021, between the Registrant and the Sponsor.(2)                                                                                              |
| 10.7    |        | Letter Agreement, dated January 20, 2022, by and among the Company, its officers, its directors and the Sponsor.(1)                                                                                       |
| 10.8    |        | Administrative Support Agreement, dated January 20, 2022, between the Company and the Sponsor.(1)                                                                                                         |
| 24.1    |   | Power of Attorney (included on the signature pages herein).                                                                                                                                               |
| 31.1*   |   | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   |
| 31.2*   |   | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15(d)-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 32.1**  |   | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                                                    |
| 32.2**  |   | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                                                    |

| * | Filed herewith. |
|---|-----------------|
| ** | Furnished herewith. |
|----|---------------------|
| (1) | Previously filed as an exhibit to our Current Report on Form 8-K filed on January 25, 2022 and incorporated by reference herein. |
|-----|----------------------------------------------------------------------------------------------------------------------------------|
| (2) | Previously filed as an exhibit to our Registration Statement on Form S-1 filed on March 1, 2021, as amended, and incorporated by reference herein. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|                      | HCM Acquisition Corp |
|----------------------|----------------------|
|                      |                      |  |
| Date: March 31, 2022 | By:                  | /s/ Shawn Matthews |
|                      |                      | Shawn Matthews |
|                      |                      | Chairman and Chief Executive Officer |

----

Table of Contents

| Name                |  | Title                                           |                          | Date           |
|---------------------|--|-------------------------------------------------|--------------------------|----------------|
|                     |  |                                                 |                          |                |
| /s/ Shawn Matthews  |  | Chief Executive Officer and Chairman            |                          | March 31, 2022 |
| Shawn Matthews      |  | (Principal Executive Officer)                   |                          |                |
|                     |  |                                                 |                          |                |
| /s/ James Bond      |  | President, Chief Financial Officer and Director |                          | March 31, 2022 |
| James Bond          |  |                                                 |                          |                |
|                |  |                                                 |                          |                |
| /s/ Steven Bischoff |  | Director                                        |      | March 31, 2022 |
| Steven Bischoff     |  |                                                 |                          |                |
|                     |  |                                                 |                          |                |
| /s/ David Goldfarb  |  | Director                                        |                          | March 31, 2022 |
| David Goldfarb      |  |                                                 |                          |                |
|                     |  |                                                 |                          |                |
| /s/ Jacob Loveless  |  | Director                                        |                          | March 31, 2022 |
| Jacob Loveless      |  |                                                 |                          |                |

----